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REMARKS FROM THE ORGANIZATIONAL REPRESENTATIVES 
Medical Quality Assessment and the American College of Physicians 
RICHARD G. FARMER, MD,* LINDA JOHNSON WHITEt 
Cleveland, Ohio 
Development of Quality those outside the field of medicine-the “consumers” (for- 
Assessment Programs merly called patients!)-as well as third party payers. 
“Quality” has become a “buzz word” in Washington, D.C., 
and elsewhere in the past few years, replacing “access” and 
“cost” as a topic of major concern in regard to health care, 
but obviously not replacing the other two as problems for the 
medical profession. Quality can have both subjective and 
objective characteristics. In the operating room or proce- 
dural unit, quality control relates to the procedures followed 
by personnel, the equipment used and other measures. 
Quality assurance has come to connote structure, process 
and outcome has become an important consideration by the 
Joint Commission on the Accreditation of Health Organiza- 
tions in the United States. 
Role of the American College of Physicians in 
Quality Assessment 
The American College of Physicians, representing over 
63,000 specialists in the specialty and subspecialties of 
internal medicine, has several major quality assessment 
functions at the national level through its Health and Public 
Policy Committee. These include: 
1. 
Quality assessment, on the other hand, is a relatively new 
concept, which has been enhanced because of the develop- 
ment in 1984 of the prospective payment system. Quality 
assessment is a formal evaluation of efficacy, effectiveness, 
necessity and indications for medical services. The ability to 
collect large amounts of data resulted from the development 
of the diagnosis related group (DRG) concept, which divided 
medical and surgical diseases and procedures into approxi- 
mately 470 categories. With use of this system, large num- 
bers of patient-related events including hospital mortality, 
length of stay and readmission rate have been reported. The 
first illustration of this is a recently published government 
survey (1) reporting data on 24 million Americans admitted 
to acute care hospitals during 1985. Thus, the grouping of 
related illnesses based on disease or organ system has 
become the hallmark of quality assessment activities, with 
the emphasis being placed on data collection and patient 
outcome rather than on processes. 
The Clinical Eficacy Assessment Project (CEAP), dating 
from 1976, uses the technique of literature-based technol- 
ogy assessment. This project had produced over 50 
position papers including the recent “medical necessity 
guidelines” of common diagnostic tests used by internists 
and others. 
2. The Clinical Privileges Project recommends the stan- 
dards of clinical competence for internists performing 
certain procedures (for example, sigmoidoscopy, upper 
gastrointestinal endoscopy and renal biopsy) (2). This 
project has produced guidelines that can be used nation- 
wide by hospital credentialing committees in the process 
of delineating appropriate privileges for medical staff 
members. 
3. 
4. 
That many of these quality assessment attempts have 
been viewed with confusion by physicians (who already 
considered themselves devoted to quality) is understand- 
able; however, it is important that physicians participate in 
quality assessment in a manner that is comprehensible to 
The Health Care Financing Subcommittee develops 
American College of Physicians’ policies on the short- 
and long-term financing of health care and is currently 
addressing financing the care of patients with acquired 
immunodeficiency syndrome (AIDS). 
The Health Care Professionals Subcommittee deals with 
health manpower needs, credentialing physicians for 
services and determining the number of physicians 
needed to perform essential services. A current project is 
evaluating the number of students currently enrolled in 
medical schools in the United States and correlating these 
with future health care needs of the population. 
The Clinical Practice Subcommittee studies quality is- 
sues directly affecting the practice of medicine by the 
physician, and has also addressed such subjects as health 
fraud and the appropriate use of drugs. 
The Health Promotion Subcommittee deals with ethical 
and professional responsibilities of the physician, as well 
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as aspects relating to preventive medicine. It is currently 
updating the American College of Physicians’ AIDS 
paper (3). 
The Subcommittee on Aging addresses issues facing the 
health care needs of older persons and the problems 
encountered by physicians who treat such patients. 
The Human Rights Subcommittee, in conjunction with 
other organizations, addresses concerns raised by physi- 
cians, acting as physicians, whose human rights may have 
been infringed on in the process. 
The Clinical Efficacy Assessment 
Project (CEAP) 
The American College of Physicians also sponsors many 
other activities that relate indirectly to quality assessment 
and provide a model for national professional organizational 
activities in this area. However, the activity that most 
directly addresses the issue of quality assessment is the 
Clinical Efficacy Assessment Project (CEAP) (4). 
Development of CEAP. In 1976, the National Association 
of Blue Shield Plans (later changed to the Blue Cross and 
Blue Shield Association [the Blues]) considered that many 
obsolete tests and procedures were still being used by 
physicians and still being reimbursed by third party payers. 
The American College of Physicians was approached, and it 
was requested that a list of procedures be reviewed under 
the auspices of the Medical Necessity Project. 
The Blues’ request came at a time when the issue of cost 
containment in health care was receiving considerable atten- 
tion. Much was being said, but few concrete actions were 
being taken. The willingness of the American College of 
Physicians to cooperate with the Blues demonstrated its 
desire to help contain the costs of health care. Initially, 28 
procedures were identified as those that “should no longer 
be reimbursed” or “should be reimbursed by report only.” 
A press conference in which the American College of 
Physicians participated was held in May 1977. 
During 1978, the American College of Physicians’ Medi- 
cal Practice Committee (forerunner of the Health and Public 
Policy Committee) was involved in another project for the 
Blues, which involved a study of the necessity of routine 
hospital admissions tests on nonsurgical patients. The rec- 
ommendation of the American Collt,ge of Physicians, which 
was endorsed by the Blues, advised against testing patients 
by hospital mandate. The recommendation was for the 
admitting physician to order the necessary tests for the 
individual patient, rather than those tests required by the 
hospital. Significant cost savings have thus occurred. 
After these activities, the American College of Physicians 
continued to review requests for the Blue Cross/Blue Shield 
medical necessity project, but desired to expand its activities 
in “technology assessment.” This resulted in a 3 year 
$650,000 grant from the John A. Hartford Foundation to 
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develop the Clinical Efficacy Assessment Project (CEAP). 
This project developed in 1981, as noted (4) and the scope 
was expanded to assess the necessity of various related 
technologies, without recommendations regarding reim- 
bursement, but to discuss appropriate uses of the technolo- 
gies studied. 
The CEAP subcommittee was formed as a part of the 
Health and Public Policy Committee of the American Col- 
lege of Physicians in 1982. Since that period of time, activ- 
ities have been greatly expanded, with considerably less 
involvement with Blue Cross/Blue Shield and a greater 
involvement with other specialty and subspecialty organiza- 
tions, particularly as reviewers of CEAP’s assessments of 
various medical technologies. 
The “CEAP process.” Thus, over a period of years, the 
“CEAP process” of technology assessment was refined and 
now includes the following: I) identification of candidate 
technologies; 2) criteria for selecting technologies to be 
evaluated; 3) selection of consultants; 4) evaluation process; 
5) definition of terms; 6) development of statement; 7) review 
of statement; 8) ratification process; 9) dissemination of 
statement; and 10) reconsideration of previously approved 
statements. 
Criteria for selecting technologies to be evaluated. These 
are of significant importance, as would be expected, and 
include the following: 1) degree of interest to practitioners of 
internal medicine, whether or not internists are directly 
responsible for its application; 2) potential for wide applica- 
tion or existing high prevalence of use; 3) potential for 
significant benefit if widely applied; and 4) potential for risk 
if widely applied, particularly in relation to potential for 
benefit. 
Selection of consultants for CEAP. The CEAP consult- 
ants are selected on the basis of training and interest in 
clinical epidemiology, statistics, economics, decision analy- 
sis and technology assessment. In addition, there is a “spe- 
cialist consultant” from the subspecialty in which the tech- 
nology assessed is primarily utilized, as well as extensive 
peer review of the reports. As stated in the Clinical Eficacy 
Assessment Project Procedural Manual: “Consultants un- 
dertake a comprehensive review of the scientific literature. 
Assessments of other organizations are reviewed and, when 
possible and necessary, information regarding ongoing clin- 
ical trials is obtained.” Assessment techniques include data 
synthesis, meta analysis, clinical decision analysis and con- 
sensus development. Risk-benefit and cost-effectiveness 
analyses are performed as feasible. 
Review and publication of CEAP recommendations. After 
review by the CEAP subcommittee after completion of the 
report by the consultants, the report and recommendations 
are presented to the Health and Public Policy Committee, 
which discusses the relative merits of the recommendation 
and either supports or modifies such. It may return the 
reports to the subcommittee if necessary. Subsequently, the 
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reports are presented to the governing board of the Ameri- 
can College of Physicians’ Board of Regents, and positions 
that are approved become “official College policy.” Thus, 
the process, although potentially lengthy, is comprehensive 
and authoritative. 
Statements by CEAP havejve components: I) a general 
description of the technology, its uses, potential uses and 
rationale; 2) an overview of the safety of the technology; 3) 
a review of the technology’s efficacy; 4) information on its 
costs: and 5) appropriate conclusions and recommendations. 
With the steadily increasing importance and interest in 
medical technology assessment (5) the CEAP process has 
received increasing recognition (6). Most CEAP statements 
now are published in the position paper section of the Annals 
oflnternal Medicine (circulation 100,000) and summaries of 
all positions are published in the American College of 
Physicians’ Observer. 
A hallmark presentation of CEAP’s work occurred in 
April 1987 with the publication of Common Diagnostic 
Tests: Use and Interpretation, edited by Harold C. Sox. Jr. 
(7). This report encompassed the results of the assessment of 
some of the most commonly used diagnostic tests by inter- 
nists, including sedimentation rate, white blood count, urine 
culture and other similar, commonly utilized tests. Although 
this resulted in much positive comment, as one would 
expect, a number of concerns were expressed that quality 
assessment techniques such as this might be used to deny 
reimbursement. However, the CEAP subcommittee, the 
Health and Public Policy Committee and the American 
College of Physicians maintain that technology assessment 
itself is independent of reimbursement issues and must be 
approached in as logical and scientific manner as possible. 
Role of the Physician 
in Quality Assessment 
As was noted in a previous review of the CEAP activities 
(6), the clinically competent internist who provides quality 
care for every patient displays six essential abilities: 1) 
clinical judgment; 2) medical knowledge; 3) clinical skills; 4) 
humanism: 5) communication skills: and 6) continuing schol- 
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arship. As has become increasingly apparent in recent years, 
the data-gathering skills required by the internist include not 
only the clinical and cognitive skills, but the ordering and 
interpretation of specific tests and an increasing technologic 
orientation to health care. Synthesis of the information 
gleaned from these various studies leads directly to decision 
making concerning diagnosis and the delivery of quality 
medical care. 
Medicine as a profession traditionally has been concerned 
about quality of care and has engaged in professional stan- 
dards setting for many years. However, because of the 
increasing cost of medical services and the increasing utili- 
zation of “high” technology procedures, there is a great deal 
of concern outside the medical profession regarding both 
cost and quality, which is often perplexing to the physician. 
Understanding of the areas of interest and concerns ex- 
pressed to the public, third party payers and government, as 
well as physicians, can lead to meaningful physician partic- 
ipation in data collection, technology assessment and quality 
assessment and can greatly benefit patients as well as have a 
positive effect on the profession itself. 
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